Status: Not yet recruiting
Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.
In Prolifertive Diabetic Retinopathy eyes with bleeding known as vitreous hemorrhage (VH) requiring a surgical procedure to remove the vitreous, called a vitrectomy, we will determine if the benefit and safety of adding a small implant that will be filled with medication called Susvimo is better with limited laser treatment.
Participants needed: 20
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Southeast Retina Center, GeorgiaUpdated: Oct 7, 2026Locations: 1
Eligibility criteria
4.1.1 Inclusion Criteria 4.1.1.1 General Inclusion Criteria [+6]
1.1.1 Exclusion Criteria [+59]